Physician
Texas Quick Care, LLC
Texas Quick Care, LLC was paid $2.50M by Medicaid between Feb 2018 and Dec 2024, across 53 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 40% of everything it billed.
33Billing provider infoTEXAS QUICK CARE, LLC
TIMPSON, TX 75975
TIMPSON, TX 75975
33aNPI1730570581assigned 02/16/2015
33bProvider typeFamily Medicine Physician
28Total paid$2.50M
24GClaims149,741
24DCodes billed53
24AFirst – last monthFeb 2018 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in Texas
Rank by total paid#43 of 1,204
Median peer was paid$31K
This provider vs. median81×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 338 | $5K | |
| 2019 | 174 | $4K | |
| 2020 | 5,106 | $94K | |
| 2021 | 28,249 | $705K | |
| 2022 | 42,612 | $682K | |
| 2023 | 50,915 | $589K | |
| 2024incomplete | 22,347 | $420K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 40% | 33,976 | 29,700 | $1.00M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 20% | 12,540 | 11,162 | $492K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 13% | 9,364 | 8,345 | $328K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 6.8% | 14,634 | 13,410 | $169K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 4.4% | 9,352 | 4,453 | $110K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2.3% | 1,229 | 1,121 | $58K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 2.0% | 652 | 604 | $49K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.9% | 691 | 639 | $48K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 1.8% | 4,757 | 2,146 | $45K |
| 87428 | 1.6% | 882 | 643 | $41K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.3% | 3,611 | 2,515 | $32K |
| 99091 | 1.2% | 188 | 186 | $29K |
41 more codes
| 99000 | <1% | 3,194 | $23K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 236 | $16K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,216 | $12K |
| 87807 | <1% | 827 | $8K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 218 | $8K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 803 | $6K |
| 90461 | <1% | 1,161 | $5K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 223 | $4K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 49 | $4K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 110 | $3K |
| 81002 | <1% | 1,018 | $2K | |
| 90756 | <1% | 71 | $1K | |
| 81025 | <1% | 114 | $746.54 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 113 | $638.60 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 828 | $545.92 |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 14 | $435.89 |
| 90674 | <1% | 73 | $412.64 | |
| 92551 | <1% | 154 | $307.69 | |
| 80305 | <1% | 42 | $290.57 | |
| 90734 | <1% | 146 | $288.98 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 141 | $192.08 |
| 90661 | <1% | 13 | $78.30 | |
| 90696 | <1% | 26 | $52.46 | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 13 | $51.31 |
| 99304 | <1% | 52 | $43.95 | |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 114 | $31.71 |
| 90715 | <1% | 136 | $31.51 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 226 | $8.57 |
| 90619 | <1% | 74 | $0.62 | |
| 1036F | 0% | 12,590 | $0.00 | |
| 90688 | 0% | 12 | $0.00 | |
| 96127 | 0% | 29 | $0.00 | |
| 90716 | 0% | 13 | $0.00 | |
| 1160F | 0% | 16,568 | $0.00 | |
| 1159F | 0% | 16,554 | $0.00 | |
| 99173 | 0% | 528 | $0.00 | |
| 90670 | 0% | 12 | $0.00 | |
| 99051 | 0% | 91 | $0.00 | |
| 90633 | 0% | 18 | $0.00 | |
| 90710 | 0% | 32 | $0.00 | |
| 90707 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialABBAS, SADIYA (EXECUTIVE DIRECTOR)